Advertisement

PentaVision

Publications

Retinal Physician

Ophthalmology Management

Ophthalmology Management

Retinal Physician

Retinal Physician

Glaucoma Physician

Glaucoma Physician

Ophthalmic Professional

Ophthalmic Professional

The Ophthalmic ASC

The Ophthalmic ASC

Presbyopia Physician

Presbyopia Physician

Corneal Physician

Corneal Physician

New Retinal Physician

New Retinal Physician

Article | 2026 Clinical Trials at the Summit

Five-Year Insights From the Pegcetacoplan Program

Lawrence J. Singerman, MD, FACS, reflects on clinical insights from the OAKS, DERBY, and GALE studies in geographic atrophy.

By: Lawrence J. Singerman, MD, FACS, Diana V. Do, MD

Retinal Physician June 24, 2026

Top Institutions in Hematology

Ranking is based on citation frequency across our internal corpus of peer-reviewed articles.

#1

California Retina Consultants

Los Angeles, CA
Strong affiliation with study investigators and multiple mentions in relevant contexts.
Key Differentiators
- Hematology
#2

The University of Texas MD Anderson Cancer Center

Houston, TX
Affiliated with award-winning physicians and reported significant trial results.
Key Differentiators
- Hematology
#3

Macula Society

N/A, N/A
Involved in annual meetings and discussions relevant to hematology.
Key Differentiators
- Hematology
#4

City of Hope National Medical Center

Duarte, CA
Contributed to discussions on treatment paradigms for complex diseases.
Key Differentiators
- Hematology
#5

Moffitt Cancer Center

Tampa, FL
Affiliated with leading study authors in hematology research.
Key Differentiators
- Hematology

Lawrence J. Singerman

Principal Investigator, Retina Specialist

Specialties: Ophthalmology

Bio: Lawrence J. Singerman, MD, FACS, is a leading retina specialist known for his extensive work in retinal clinical trials, particularly in the area of geographic atrophy and novel therapies such as pegcetacoplan. He has served as a principal investigator in multiple pivotal clinical studies, including the phase 2 FILLY trial, phase 3 OAKS and DERBY studies, and the GALE extension study. Dr. Singerman is recognized for his leadership in advancing retinal therapeutics and has contributed important clinical insights into the treatment of retinal diseases. With over a decade of experience running an expanding retina clinical practice, Dr. Singerman mentors emerging retinal physicians and emphasizes the importance of clinical research in improving patient outcomes. His role at Clinical Trials at the Summit highlights his dedication to collaboration and knowledge-sharing among retina specialists and industry partners.

Diana V. Do, MD

Retina Specialist

Specialties: Ophthalmology

Bio: Diana V. Do, MD, is a retina specialist and author for Retinal Physician. Her work focuses on ophthalmology and retinal disease, with interest in clinical trials, practice management, and emerging therapies for retinal conditions. In her Retinal Physician column, Dr. Do discusses developments in retina care, including clinical research collaboration, international clinical trial infrastructure, and investigational treatments for neovascular age-related macular degeneration and diabetic macular edema. She has also referenced her training connections with the Wilmer Eye Institute.